Immune Modulatory Vaccines Reprogram the Tumor Microenvironment
Could immunomodulatory vaccines reshape the future of cancer treatment? Professor Mads Hald Andersen, Director of the National Center for Cancer Immune Therapy at Copenhagen University Hospital Herlev and Professor at the University of Copenhagen, presents a new approach targeting the tumor microenvironment — with the potential to enhance the effect of existing immunotherapies.
